Tandem Diabetes Care | TNDM - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.13B 1.3B 2025-12
Accuray USD 61.87M 19.3M 2025-09
Align Technology USD 3.96B 44.68M 2025-09
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
ICU Medical USD 2.12B 3.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 81.54B 3.07B 2025-12
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Orthofix International USD 450.04M 7.55M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12